Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
J Med Genet. 2022 Jul;59(7):632-643. doi: 10.1136/jmedgenet-2021-107904. Epub 2021 Nov 29.
Epithelial tubo-ovarian cancer (EOC) has high mortality partly due to late diagnosis. Prevention is available but may be associated with adverse effects. A multifactorial risk model based on known genetic and epidemiological risk factors (RFs) for EOC can help identify women at higher risk who could benefit from targeted screening and prevention.
We developed a multifactorial EOC risk model for women of European ancestry incorporating the effects of pathogenic variants (PVs) in , , , and , a Polygenic Risk Score (PRS) of arbitrary size, the effects of RFs and explicit family history (FH) using a synthetic model approach. The PRS, PV and RFs were assumed to act multiplicatively.
Based on a currently available PRS for EOC that explains 5% of the EOC polygenic variance, the estimated lifetime risks under the multifactorial model in the general population vary from 0.5% to 4.6% for the first to 99th percentiles of the EOC risk distribution. The corresponding range for women with an affected first-degree relative is 1.9%-10.3%. Based on the combined risk distribution, 33% of PV carriers are expected to have a lifetime EOC risk of less than 10%. RFs provided the widest distribution, followed by the PRS. In an independent partial model validation, absolute and relative 5-year risks were well calibrated in quintiles of predicted risk.
This multifactorial risk model can facilitate stratification, in particular among women with FH of cancer and/or moderate-risk and high-risk PVs. The model is available via the CanRisk Tool (www.canrisk.org).
上皮性输卵管卵巢癌(EOC)死亡率高,部分原因是诊断较晚。目前已有预防措施,但可能会伴随不良反应。基于上皮性输卵管卵巢癌已知的遗传和流行病学风险因素(RFs)的多因素风险模型,可以帮助确定处于高风险的女性,她们可能受益于靶向筛查和预防。
我们为欧洲血统的女性开发了一种上皮性输卵管卵巢癌多因素风险模型,纳入了 、 、 、 和 致病性变异(PVs)的影响、任意大小的多基因风险评分(PRS)、RFs 的影响以及通过合成模型方法明确的家族史(FH)。PRS、PV 和 RFs 被假定为相乘作用。
基于目前可用于上皮性输卵管卵巢癌的 PRS,它解释了上皮性输卵管卵巢癌多基因变异的 5%,在一般人群中,多因素模型下的终生风险在上皮性输卵管卵巢癌风险分布的第 1 到 99 百分位从 0.5%到 4.6%不等。对于有一级亲属受影响的女性,对应的范围为 1.9%-10.3%。基于综合风险分布,预计 33%的 PV 携带者的终生上皮性输卵管卵巢癌风险低于 10%。RFs 提供了最广泛的分布,其次是 PRS。在独立的部分模型验证中,五分位预测风险的绝对和相对 5 年风险校准良好。
这种多因素风险模型可以促进分层,特别是在有癌症家族史和/或中等风险和高风险 PVs 的女性中。该模型可通过 CanRisk 工具(www.canrisk.org)获得。